Simvastatin Versus MTA in Pulpotomy of Immature Permanent Molars

Early Phase 1UnknownNCT05878158

Ahmad Elheeny128 enrolled

Overview

the study will be done to evaluate the clinical and digital radiographic success of simvastatin versus MTA in pulpotomy of immature permanent molars

the clinical and digital radiographic success of simvastatin versus MTA in pulpotomy of immature permanent molars for the following patients which include: Healthy children aged from 6 to 8 years who will be classified as Class I or II Children according to the American Society of Anaesthesiologists (ASA) will be included. Children with severe behavioral, or emotional disabilities, and medically compromised children will be excluded.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

128

Conditions

Pulp Exposure, Dental

Interventions

SimvastatinDRUG

pulpotomy of immature permanent teeth

Eligibility

Sex: ALLMin age: 6 YearsMax age: 8 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Healthy children aged from 6 to 8 years * Children with severe behavioral, or emotional disabilities, and medically compromised children will be excluded. * Deep carious lesions of the first permanent immature molars with signs \& symptoms of reversible pulpitis will be included * Normal radiographic findings and immature roots

Locations (1)

Faculty of Dentistry

Minya, Egypt

RECRUITING

Outcomes

Primary Outcomes

Presence or absence of pain

clinical assessment

Time frame: one year

Secondary Outcomes

Dentin wall thickness

radiographic assessment

Time frame: 18 months

Central Contacts

mohamed aboalftooh, doctora

CONTACT

01092183998 Doctormasmanlover22@gmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.